MedKoo Cat#: 471051 | Name: RJR 2429 dihydrochloride
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

RJR 2429 dihydrochloride is a nicotinic acetylcholine receptor (AChR) agonist that displays selectivity for α4β2.

Chemical Structure

RJR 2429 dihydrochloride
RJR 2429 dihydrochloride
CAS#1021418-53-0

Theoretical Analysis

MedKoo Cat#: 471051

Name: RJR 2429 dihydrochloride

CAS#: 1021418-53-0

Chemical Formula: C12H18Cl2N2

Exact Mass:

Molecular Weight: 261.19

Elemental Analysis: C, 55.18; H, 6.95; Cl, 27.14; N, 10.73

Price and Availability

Size Price Availability Quantity
5mg USD 250.00
10mg USD 340.00
25mg USD 800.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
RJR 2429 dihydrochloride, RJR2429 dihydrochloride, RJR-2429 dihydrochloride, RJR 2429 2HCl, RJR 2429 HCl
IUPAC/Chemical Name
2-(3-pyridinyl)-1-azabicyclo[2.2.2]octane, dihydrochloride
InChi Key
PIUNXHHZRIUBOV-UHFFFAOYSA-N
InChi Code
InChI=1S/C12H16N2.2ClH/c1-2-11(9-13-5-1)12-8-10-3-6-14(12)7-4-10;;/h1-2,5,9-10,12H,3-4,6-8H2;2*1H
SMILES Code
[H]Cl.[H]Cl.N1(CC2)C(C3=CC=CN=C3)CC2CC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO and water
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO and water
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Product Data
Biological target:
RJR 2429 dihydrochloride is a potent nAChR agonist that displays selectivity for α4β2 (Ki = 1 nM) and α1βγδ subtypes (EC50 values 297 and 55 nM, respectively). RJR 2429 dihydrochloride induces dopamine release from striatal neurons (EC50 = 2 nM) and inhibits ion flux in thalamic neurons (IC50 = 154 nM). It is a putative α3β4 agonist that potentiates catecholamine release.
In vitro activity:
RJR-2429 is less potent in activating nAChRs in the clonal cell line PC12, with EC50 = 1100 +/- 230 nM and Emax = 85 +/- 20% when compared with nicotine. The activation of a putative alpha 3 beta 4-containing nAChR in PC12 by RJR-2429 reveals a potency intermediate between nicotine and epibatidine (EC50 of 20,000 nM for nicotine and 30 nM for epibatidine). Reference: J Pharmacol Exp Ther. 1998 Mar;284(3):886-94. https://pubmed.ncbi.nlm.nih.gov/9495846/
In vivo activity:
This study characterized nicotinic acetylcholine receptors involved in the release of catecholamines from the rat adrenal gland. The efficacies of these agonists are as follows: (+/-) epibatidine >> RJR-2429>(-)-cytisine>(-)-nicotine >> RJR-2403. These results suggest that alpha3beta4 nicotinic receptors are involved in the release of catecholamines from the rat adrenal gland. Reference: Eur J Pharmacol. 2002 Jun 20;446(1-3):83-7. https://pubmed.ncbi.nlm.nih.gov/12098588/
Solvent mg/mL mM
Solubility
DMSO 100.0 382.86
Water 100.0 382.86
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 261.19 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Bhatti BS, Strachan JP, Breining SR, Miller CH, Tahiri P, Crooks PA, Deo N, Day CS, Caldwell WS. Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands. J Org Chem. 2008 May 2;73(9):3497-507. doi: 10.1021/jo800028q. Epub 2008 Mar 26. PMID: 18363376. 2. Bencherif M, Schmitt JD, Bhatti BS, Crooks P, Caldwell WS, Lovette ME, Fowler K, Reeves L, Lippiello PM. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1998 Mar;284(3):886-94. PMID: 9495846. 3. Yokotani K, Okada S, Nakamura K. Characterization of functional nicotinic acetylcholine receptors involved in catecholamine release from the isolated rat adrenal gland. Eur J Pharmacol. 2002 Jun 20;446(1-3):83-7. doi: 10.1016/s0014-2999(02)01819-8. PMID: 12098588.
In vitro protocol:
1. Bhatti BS, Strachan JP, Breining SR, Miller CH, Tahiri P, Crooks PA, Deo N, Day CS, Caldwell WS. Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands. J Org Chem. 2008 May 2;73(9):3497-507. doi: 10.1021/jo800028q. Epub 2008 Mar 26. PMID: 18363376. 2. Bencherif M, Schmitt JD, Bhatti BS, Crooks P, Caldwell WS, Lovette ME, Fowler K, Reeves L, Lippiello PM. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): a selective ligand at nicotinic acetylcholine receptors. J Pharmacol Exp Ther. 1998 Mar;284(3):886-94. PMID: 9495846.
In vivo protocol:
1. Yokotani K, Okada S, Nakamura K. Characterization of functional nicotinic acetylcholine receptors involved in catecholamine release from the isolated rat adrenal gland. Eur J Pharmacol. 2002 Jun 20;446(1-3):83-7. doi: 10.1016/s0014-2999(02)01819-8. PMID: 12098588.
1. Playa, H.et al. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2). Bioorg. Med. Chem. Lett. 2014, 24(24), 5801-5804. 2. Bhatti, B.et al.Synthesis of 2-(pyridin-3-yl)-1-azabicyclo[3.2.2]nonane, 2-(pyridin-3-yl)-1-azabicyclo[2.2.2]octane, and 2-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, a class of potent nicotinic acetylcholine receptor-ligands. J. Org. Chem. 2008, 73(9), 3497-3507. 3. Yokotani K. et al Characterization of functional nicotinic acetylcholine receptors involved in catecholamine release from isolated rat adrenal gland. Eur.J.Pharmacol. 2002, 446(1-3):83-7 4. Bencherif, M. et al. The heterocyclic substituted pyridine derivative (+/-)-2-(-3-pyridinyl)-1-azabicyclo[2.2.2]octane (RJR-2429): A selective ligand at nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 1998, 284(3), 886-894